Home › NDC Lookup › RxCUI directory › RxCUI 2566816

Dextromethorphan hydrobromide 0.667 MG/ML / guaifenesin 6.667 MG/ML / phenylephrine hydroc... — RxCUI 2566816

RxNorm drug concept · Semantic clinical drug
RxCUI 2566816 Semantic clinical drug · SCD ● Current RxNorm concept 5 FDA products 7 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2566816
Official nameDextromethorphan hydrobromide 0.667 MG/ML / guaifenesin 6.667 MG/ML / phenylephrine hydrochloride 0.333 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asdextromethorphan hydrobromide 10 MG / guaifenesin 100 MG / phenylephrine hydrochloride 5 MG per 15 ML Oral Solution; dextromethorphan HBr 10 MG / guaiFENesin 100 MG / phenylephrine HCl 5 MG in 15 mL Oral Solution
FDA products mapped5
Package NDCs mapped7
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Phenylephrine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Yes, it's the same active ingredient, but used in very different ways depending on the form. The nasal spray delivers a tiny amount directly to the nasal lining to temporarily shri...
  • I see phenylephrine in nasal sprays at the pharmacy AND as an IV drug in the hospital — is it really the same medication?
  • You should check with your doctor first. Phenylephrine constricts blood vessels, which can raise blood pressure and put extra strain on the heart — even from a nasal spray. If you...
  • Can I use the nasal spray if I have high blood pressure or heart disease?
📖 Read our full Phenylephrine guide →

🕸️ Concept Web — How Dextromethorphan hydrobromide 0.667 MG/ML / guai... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Dextromethorphan hydrobromide 0.667 MG/ML / guaifenesin 6.667 MG/ML / phenylephrine hydrochloride 0.333 MG/ML Oral Solution RxCUI 2566816

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 6

    The active substance itself — no strength, form, or brand attached yet.

    • Dextromethorphan 3289
    • Guaifenesin 5032
    • Phenylephrine 8163
    • Dextromethorphan / guaifenesin / phenylephrine 214494
    • Dextromethorphan hydrobromide 102490
    • Phenylephrine hydrochloride 8164
  2. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Dextromethorphan / guaifenesin / phenylephrine Oral Solution 375427
    • Dextromethorphan hydrobromide / guaifenesin / phenylephrine hydrochloride Oral Solution 2645876
    • Dextromethorphan / guaifenesin / phenylephrine Oral Liquid Product 1154857
    • Dextromethorphan / guaifenesin / phenylephrine Oral Product 1154858
    • Dextromethorphan hydrobromide / guaifenesin / phenylephrine hydrochloride Oral Liquid Product 2663136
    • Dextromethorphan hydrobromide / guaifenesin / phenylephrine hydrochloride Oral Product 2663549
    • Oral Solution 316968
    • Oral Liquid Product 1151137
    • +1 more in this family
  3. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Dextromethorphan hydrobromide 0.667 MG/ML 1014004
    • Guaifenesin 6.667 MG/ML 2566815
    • Phenylephrine hydrochloride 0.333 MG/ML 1039296
  4. Packs 1

    Fixed collections of drugs packaged and sold together, like dose packs.

Showing up to 8 concepts per family — 18 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

📦 FDA Products & Package NDCs

5 products · 7 package NDCs
7 package NDCs map to RxCUI 2566816 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00363-6238-08 236 mL in 1 BOTTLE, PLASTIC (0363-6238-08) Walgreen Daytimel Kids Cold Cough plus Mucus WALGREENS CO. 2023-03-01
69423-0778-08 236 mL in 1 BOTTLE, PLASTIC (69423-778-08) Vicks DayQuil Kids BERRY COLD and COUGH plus MUCUS The Procter & Gamble Manufacturing Company 2023-06-06
69423-0778-16 2 BOTTLE, PLASTIC in 1 CELLO PACK (69423-778-16) / 236 mL i... Vicks DayQuil Kids BERRY COLD and COUGH plus MUCUS The Procter & Gamble Manufacturing Company 2026-01-20
69423-0780-16 1 KIT in 1 PACKAGE (69423-780-16) * 236 mL in 1 BOTTLE, PL... Vicks DayQuil NyQuil BERRY Kids COLD and COUGH plus The Procter & Gamble Manufacturing Company 2023-06-06
69423-0780-24 1 KIT in 1 PACKAGE (69423-780-24) * 236 mL in 1 BOTTLE, PL... Vicks DayQuil NyQuil BERRY Kids COLD and COUGH plus The Procter & Gamble Manufacturing Company 2023-06-06
69423-0946-08 236 mL in 1 BOTTLE, PLASTIC (69423-946-08) Vicks DayQuil Kids Cold Cough plus Mucus The Procter & Gamble Manufacturing Company 2021-07-08
69423-0993-16 1 KIT in 1 PACKAGE (69423-993-16) * 236 mL in 1 BOTTLE, PL... Vicks DayQuil Kids Honey and Vicks NyQuil Kids Honey COLD and COUGH plus The Procter & Gamble Manufacturing Company 2022-07-12
Observed labelers: The Procter & Gamble Manufacturing Company (6) · WALGREENS CO. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.